Actively Recruiting
Pancreatitis - Microbiome as Predictor of Severity II
Led by University Medical Center Goettingen · Updated on 2025-07-15
700
Participants Needed
1
Research Sites
191 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the orointestinal microbiome and microbial derived metabolome in patients suffering from acute pancreatitis as a biomarker for severity. The main questions it aims to answer are: * Can the orointestinal microbiome robustly predict the course of acute pancreatitis? * How does the microbiome impact the severity of an acute pancreatitis? Buccal/ rectal swabs, plasma and stool is collected from patients with acute pancreatitis within 48h after hospital admission.
CONDITIONS
Official Title
Pancreatitis - Microbiome as Predictor of Severity II
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with initial diagnosis (< 48h) of acute pancreatitis
- Age 63 18 years
- Patients able to understand/ give their written consent
You will not qualify if you...
- Recurrent acute pancreatitis (>2 previous episodes)
- Clinical or imaging signs of chronic pancreatitis
- Referred patients with length of hospital stay > 48h
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Goettingen
Göttingen, Lower Saxony, Germany, 37075
Actively Recruiting
Research Team
C
Christoph Ammer-Herrmenau, Dr
CONTACT
J
Jacob Hamm, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here